ABSSF yields 1.78% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, ABSSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABSSF + PFE for your $10,000?
AirBoss of America Corp., together with its subsidiaries, develops, manufactures, and markets rubber-based products for automotive, heavy commercial, construction and infrastructure, oil and gas, and defense industries in Canada, the United States, and internationally. It operates through three segments: AirBoss Defense Group, Rubber Solutions, and Engineered Products. The AirBoss Defense Group segment develops, manufactures, and sells healthcare protective equipment, personal respiratory protective products, rapid deployment negative pressure isolation shelters, and cold weather combat footwear, as well as chemical, biological, radioactive, nuclear, and explosive protective equipment for military, law enforcement, healthcare and industrial providers, and first responders. The Rubber Solutions segment is involved in the development and manufacture of custom rubber formulations and compounds, calendered and extruded materials, and molded products for use in various applications and industries, including automotive, heavy industry, rollers, conveyor belting, defense, construction and infrastructure, mining, transportation, and oil and gas. The Engineered Products segment designs, engineers, manufactures, and sells rubber, synthetic rubber, and rubber-to-metal bonded products that are used to eliminate or control undesired vibration and noise for use in automotive, electric vehicle, heavy truck and off-highway, industrial, and defense industries. The company was formerly known as IATCO Industries Inc. and changed its name to AirBoss of America Corp. in April 1994. AirBoss of America Corp. is headquartered in Newmarket, Canada.
Full ABSSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.